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Introduction
There may be differences between office blood pressure (BP) and 
out-of-office BP (home BP or ambulatory BP). These differences 
may have implications for long-term prognosis.1)2) High BP is 
a well-known cardiovascular disease risk factor, and sustained 
hypertension (HT) is related to increased cardiovascular events.3) 
Similarly, masked hypertension and isolated out-of-office HT, also 
show increased cardiovascular events compared to white coat 
hypertension (WCH) and normotension (NT).4)5) 
WCH, often called isolated office HT, has been associated with 
adverse cardiovascular events and target organ damage compared 
to NT in some studies.6-8) Long-term follow-up of WCH data reveal 
an association with target organ damage or stroke independent of 
mean arterial pressure.8)9) However, other studies did not find such 
a relationship.4)5)
Recently, besides high BP, blood pressure variability (BPV) is being 
reported as another independent risk factor for cardiovascular 
events.9)10) BPV refers to the fluctuation of BP with time. BPV is 
defined as either the overall variability during a period of time, such as 
the standard deviation (SD), or the average of the absolute difference 
between serial readings, such as average real variability (ARV).9) BPV 
has the potential to be a strong predictor of stroke, independent 
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of mean systolic BP.11-13) Increased large artery stiffness and left 
ventricular mass can be present in subjects with high BPV.14)15) 
WCH may be a marker of a reaction to stress, such as a visit 
to the doctor’s office that manifests with a BP surge and results 
in BPV.16) The purpose of this study is to evaluate the relationship 
between WCH and BPV. We postulate that subjects with WCH, 
which plays a controversial role in cardiovascular events, may have 
higher BPV than those with NT. 
Subjects and Methods
Study population
This study was conducted using data from the Korean Ambulatory 
BP Monitoring (Kor-ABP) Registry. This data was compiled in 
a multicenter observational study involving 23 secondary and 
tertiary hospitals. From 2009 to 2013, 5302 subjects were enrolled 
in this registry. The methodology used in the registry and details 
regarding inclusion and exclusion criteria are published by Kang 
et al.17)
Only qualified recordings with more than 80% valid BP measurements 
were included in this study. After excluding outlying and missing 
data, the number of eligible subjects was 2367. We further excluded 
subjects who had a medical history of HT (n=900) and selected 
subjects for this study who had no known medical history of HT 
(n=1467). After exclusion of the subjects with a medical history of 
myocardial infarction and stroke, 1398 subjects remained in the 
final analysis (Fig. 1). 
The study protocol was reviewed and approved by the institutional 
review board of each participating institution. Ambulatory BP 
monitoring (ABPM) data were collected from the patients of 
referral hospitals after obtaining written informed consent.
Blood pressure parameters and classification of subjects
After resting for at least 5 minutes, office BP was measured by a 
physician in the referral hospital outpatient clinic using a validated 
automated device (UA-767, A & D company, San Jose, CA, USA), 
with the subject in a sitting position and arm supported at heart 
level. The average of two measurements was used for the analysis. 
High office BP was defined as an average systolic BP≥140 mmHg or 
an average diastolic BP≥90 mmHg. 
Daytime and nighttime BPs were calculated using the narrow 
fixed 30-minute interval method from the ABPM. However, the 
permissible limit of BP measuring frequency was more than every 
30 minutes in the daytime and every 60 minutes in the nighttime. 
Variable intervals were permitted according to the referral center 
preferences within the limit (mean±SD, daytime: 19.87±7.0 min and 
nighttime: 34.16±10.5 min). The average of daytime BP values was 
calculated using the BP values obtained from 6 a.m. to 10 p.m., and 
nighttime BP values were calculated using the BP values from 10 
p.m. to 6 a.m. High average daytime ambulatory BP was defined as 
an average daytime systolic BP≥135 mmHg or an average daytime 
Fig. 1. Flow chart of study population. Kor-ABP: Korean ambulatory blood pressure, BP: blood pressure.
5302 individuals enrolled
Kor-ABP registry
2367 subjects
1467 subjects
1398 subjects were analysis in this study
2935 individuals excluded due to following conditions
・average systolic BP valued greater than 
    200 mmHg or lower than 70 mmHg
・average diastolic BP was greater than 
    140 mmHg or lower than 50 mmHg
・less than 80% of valid blood pressure
    measurements
900 individuals who have medical history of
hypertension were excluded
69 patients who have medical history of
stroke or myocardial infarction were excluded
367In Sook Kang, et al.
http://dx.doi.org/10.4070/kcj.2016.46.3.365www.e-kcj.org
diastolic BP≥85 mmHg.  Pulse pressure was calculated by subtracting 
the mean diastolic BP from the mean systolic BP. All subjects were 
classified into four groups according to their office BP and average 
daytime ambulatory BP5)18): (1) NT (office BP<140/90 mmHg and 
average daytime ambulatory BP<135/85 mmHg), (2) WCH (high 
office BP and average daytime ambulatory BP<135/85 mmHg), 
(3) masked hypertension (MHT, office BP<140/90 mmHg and high 
average daytime ambulatory BP), and (4) sustained hypertension 
(SHT, high office BP and high average daytime ambulatory BP).
Definitions of blood pressure variability
The SD of daytime and nighttime (systolic and diastolic) BP was 
calculated. 
The ARV of BP was calculated using the following formula19): 
where N is the number of valid BP measurements and K is the 
order of measurements from each subject in the ABPM data 
corresponding to a given subject.
The coefficient of variation (CoV) was calculated from the ratio 
of the SD to the mean.
Statistical analyses 
Baseline characteristics of subjects were compared using the 
chi-square test for categorical variables and one-way analysis 
of variance (ANOVA) test for continuous variables. Values of 
continuous variables were expressed as the mean±SD. A paired 
t-test was used to determine whether there was any difference 
between the SD and ARV values among groups. The significant 
values by one-way ANOVA BPV were entered into the general 
linear model to perform analysis of covariance for adjusting 
confounding variables, including sex, age, given medical history 
of diabetes mellitus, body mass index (BMI), serum creatinine, and 
cholesterol level. We performed post-hoc analysis with the least 
significant difference test. Adjusted values of continuous variables 
were expressed as the adjusted mean±standard error. A value of 
p<0.05 was considered statistically significant. Statistical analysis 
was performed using Statistical Package for Social Science version 
19.0 (SPSS Inc., Chicago, IL, USA). 
Results
Characteristics of the four groups
The mean age of the total 1398 subjects was 52.4±15.4 years 
and 47.7% were female. The average BMI of the four groups was 
Table 1. Baseline characteristics
Total
n=1398
NT
n=364
MHT
n=122
WCH
n=254
SHT
n=658 p
Age (years) 52.4±15.4 53.9±17.7 54.5±14.5† 51.0±16.4* 51.7±13.7* 0.027
AC (cm) 87.6±10.2 86.7±9.8 89.7±11.1*† 85.7±10.7 88.2±9.9*† <0.001
BMI (kg/m2) 24.3±3.3 23.3±3.2 24.9±3.3*† 24.0±3.4* 24.8±3.1*† <0.001
Creatinine (mg/dL) 0.86±0.3 0.83±0.2 0.83±0.2 0.83±0.2 0.90±0.4*† 0.002
Glucose (mg/dL) 104.1±25.8 103.6±28.6 108.6±31.0 104.1±22.4 103.6±24.6 0.615
Total cholesterol (mg/dL) 191.1±40.5 180.6±40.5 195.5±43.5* 194.3±38.6* 194.9±39.8* <0.001
Female 667 (47.7) 187(48.6) 57 (46.7) 133 (52.4) 290 (44.1) 0.053
Medical history
Diabetes mellitus 81 (6.1) 26 (7.7) 7 (5.9) 15 (6.0) 33 (5.2) 0.516
Dyslipidemia 163 (12.6) 44 (13.1) 15 (13.3) 31 (13.1) 73 (12.0) 0.950
Heart failure 20 (1.4) 10 (2.8) 0 (0) 3 (1.2) 7 (1.1) 0.720
Chronic renal failure 61 (5.1) 20 (6.5) 3 (3.0) 8 (3.8) 30 (5.2) 0.406
Other factors
Current smoker 259 (18.6) 76 (20.9) 24 (19.8) 32 (12.7) 127 (19.4) 0.058
Exercise‡ 127 (34.8) 127 (34.9) 38 (31.1) 90 (35.4) 193 (29.3) 0.393
Well-sleep 7431 (55.1) 191(54.3) 60 (51.3) 139 (57.2) 351 (55.5) 0.840
Values are presented as mean±standard deviation or n (%). *p<0.05 vs. normal, †p<0.05 vs. WCH. ‡Exercise more than three times per week. 
NT: normotension, MHT: masked hypertension, WCH: white coat hypertension, SHT: sustained hypertension, AC: abdominal circumference, BMI: body mass index 
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24.3±3.3 kg/m2. The most common group was SHT (n=658, 47.1%), 
followed by NT (n=364, 26.0%), WCH (n=254, 18.2%), and MHT 
(n=122, 8.7%). The baseline clinical characteristics of the groups 
are listed in Table 1. There were no significant differences in the 
proportion of female subjects, glucose levels, exercise, sleep quality, 
and medical history of diabetes mellitus between the groups. 
Subjects in the NT and MHT groups were older than those in the 
WCH and SHT groups (p=0.027). The WCH group had the smallest 
average abdominal circumference (85.7±10.7 cm, p<0.001). The 
proportion of cigarette smokers was lower in the WCH group than 
the other groups (p=0.005). Compared to the NT group, the other 
three groups had higher lower density-cholesterol levels (p<0.001). 
Office blood pressure and ambulatory blood pressure moni-
toring 
By definition, office BPs were higher in the WCH and SHT groups 
than in the NT and MHT groups. The results of ABPM were higher in 
the MHT and SHT groups than in the other two groups. Additionally, 
the difference in systolic office BP within the NT and MHT versus 
the WCH and SHT groups was significant (all p<0.001, Table 2). The 
Table 2. Blood pressure values
Total NT MHT WCH SHT p
Office SBP 142.8±20.9 119.9±13.0 129.3±9.2*†‡ 148.7±13.4* 155.7±15.6*† <0.001
Office DBP 88.5±15.3 75.1±9.3 78.1±9.0*†‡ 91.3±12.5* 96.8±13.5*† <0.001
Office HR 77.2±14.2 73.4±12.5 75.9±12.1†‡ 79.0±16.6* 79.0±14.1* <0.001
ABP-DSBP 138.6±16.0 122.8±10.6 146.3±9.0*†‡ 129.0±8.2* 149.6±11.4*† <0.001
ABP-DDBP 87.7±12.2 76.6±6.9 92.8±10.2*† 80.4±6.2* 96.2±9.3*† <0.001
ABP-DHR 76.3±9.7 73.4±9.7 78.1±9.8*† 74.8±9.1 78.0±9.5*† <0.001
ABP-NSBP 125.2±17.3 113.8±14.0 130.6±14.4*†‡ 116.8±13.2* 133.8±15.7*† <0.001
ABP-NDBP 78.0±11.9 69.9±9.5 80.3±9.9*†‡ 71.9±8.8* 84.4±10.5*† <0.001
ABP-NHR 63.6±9.3 62.7±9.4 63.8±8.9 62.4±9.5 64.7±9.1*† <0.001
ABP-DPP 50.6±9.8 46.2±7.8 53.5±10.1*† 48.6±7.2* 53.2±10.6*† <0.001
Values are presented as mean±standard deviation. *p<0.05 vs. NT, †p<0.05 vs. WCH, ‡p<0.05 vs. SHT. NT: normotension, MHT: masked hypertension, 
WCH: white coat hypertension, SHT: sustained hypertension, SBP: systolic blood pressure, DBP: diastolic blood pressure, HR: heart rate, ABP: 24 hour am-
bulatory blood pressure, DSBP: daytime SBP, DDBP: daytime DBP, DRR: daytime heart rate, NSBP: nighttime SBP, NDBP: nighttime DBP, NHR: nighttime 
heart rate, DPP: daytime pulse pressure
Table 3. Blood pressure variability
Total NT MHT WCH SHT p
SD of day SBP 15.4±5.9 16.0±5.9 15.6±6.0 15.7±6.1 15.0±5.8* 0.075
SD of day DBP 12.8±5.3 12.7±5.1 13.7±6.2 12.8±5.2 12.7±5.2 0.264
SD of night SBP 11.0±5.3 10.9±5.1 10.8±4.8 10.5±5.1 11.4±5.5† 0.114
SD of night DBP 8.4±4.2 8.1±4.1 8.7±4.5 7.8±3.1 8.8±4.5*† 0.004
ARV of 24-h SBP 19.1±9.4 16.9±8.4 17.7±7.8† 22.7±10.8* 19.1±9.2*† <0.001
ARV of 24-h DBP 15.1±7.4 12.6±6.0 14.5±6.8*† 17.8±10.0* 15.5±6.5*† <0.001
ARV of day SBP 18.1±9.2 16.5±8.4 16.8±7.8† 21.6±10.5* 17.8±9.0*† <0.001
ARV of day DBP 14.3±7.4 12.2±6.0 13.7±7.1*† 17.1±9.8* 14.4±6.6*† <0.001
CoV of day SBP 0.11±0.04 0.13±0.05 0.11±0.04*† 0.12±0.05* 0.10±0.04*† <0.001
CoV of day DBP 0.15±0.07 0.17±0.07 0.15±0.07* 0.16±0.07 0.13±0.06*† <0.001
CoV of night SBP 0.09±0.04 0.10±0.05 0.08±0.04* 0.04±0.02 0.09±0.04* <0.001
CoV of night DBP 0.11±0.05 0.12±0.06 0.11±0.06 0.11±0.05 0.10±0.05* 0.010
Values are presented as mean±standard deviation. *p<0.05 vs. NT, †p<0.05 vs. WCH. NT: normotension, MHT: masked hypertension, WCH: white coat hy-
pertension, SHT: sustained hypertension, SD: standard deviation, SBP: systolic blood pressure, DBP: diastolic blood pressure, ARV: average real variability, 
CoV: coefficient of variation
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MHT group had higher office BP values than the NT group, and 
the SHT group had higher office BP values than the WCH group 
(p<0.001). Similarly in ABPM, the difference in 24-h systolic and 
diastolic BP was evident within NT and WCH groups versus the MHT 
and SHT groups (all p<0.001). 
Blood pressure variability
The BPV values are presented in Table 3. With regard to daytime 
systolic BPV, the SD of the NT group was highest, followed by 
the WCH, MHT, and SHT groups, although only the NT and SHT 
groups showed significant differences. Contrary to SD, the daytime 
systolic BP ARV of the NT and SHT groups showed lower mean 
Table 4. Values of adjusted blood pressure variability 
NT MHT WCH SHT p
SD of day SBP 16.0±0.5 15.2±0.7 15.7±0.5 15.1±0.4 0.289
SD of day DBP 12.8±0.4 13.7±0.7 12.7±0.5 12.7±0.4 0.445
SD of night SBP 11.3±0.4 10.9±0.7 10.9±0.5 11.7±0.4 0.309
SD of night DBP 8.4±0.3 8.7±0.5 7.9±0.4 8.7±0.3* 0.123
ARV of 24-h SBP 16.7±0.7 17.0±1.1† 22.9±0.8* 19.4±0.6*† <0.001
ARV of 24-h DBP 11.4±0.6 14.0±0.9*† 16.8±0.6* 14.3±0.5*† <0.001
ARV of day SBP 16.4±0.7 16.1±1.1† 21.8±0.8* 18.2±0.6*† <0.001
ARV of day DBP 11.2±0.6 13.5±0.9*† 16.2±0.6* 13.4±0.5*† <0.001
CoV of day SBP 0.13±0.003 0.11±0.005*† 0.12±0.003* 0.10±0.002*† <0.001
CoV of day DBP 0.17±0.004 0.15±0.007* 0.16±0.005 0.14±0.003*† <0.001
CoV of night SBP 0.10±0.003 0.08±0.005* 0.09±0.003 0.08±0.002* 0.001
CoV of night DBP 0.12±0.003 0.11±0.006 0.11±0.004 0.10±0.002* 0.003
Values are presented as adjusted mean±standard error. Values are adjusted for sex, age, given medical history of diabetes mellitus, body mass index, serum 
creatinine, and cholesterol level. *p<0.05 vs. NT, †p<0.05 vs. WCH. NT: normotension, MHT: masked hypertension, WCH: white coat hypertension, SHT: sus-
tained hypertension, SD: standard deviation, SBP: systolic blood pressure, DBP: diastolic blood pressure, ARV: average real variability, CoV: coefficient of 
variation
Fig. 2. The differences between SD and ARV within groups. The WCH group showed a large difference in the SD and ARV, which was followed by SHT. 
The NT and MHT groups did not show differences in daytime systolic BPV (A) or daytime diastolic BPV (B). *p<0.001. SD: standard deviation, ARV: average 
real variability, WCH: white coat hypertension, SHT: sustained hypertension, NT: normotension, MHT: masked hypertension, BPV: blood pressure variability, 
NS: non-significant. 
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values compared to the other two groups. The WCH group had 
the highest value. A similar pattern was present in the daytime 
diastolic BPV. Even though there was no significant difference in 
the SD of daytime diastolic BP, the means of the ARV were highest 
in the WCH group, followed by the SHT, MHT, and NT groups 
(Table 3 and Fig. 2). There was no significant difference between 
the SD and ARV values in the NT and MHT groups (Fig. 2A and 
2B). However, the SHT and WCH groups had a significantly higher 
ARV than SD (p<0.001); this difference was highest in the WCH 
group (Fig. 2A and 2B). After adjusting for the covariates of sex, 
age, diabetes mellitus, BMI, serum creatinine, and cholesterol level, 
ARV means still showed significant differences between groups 
(Table 4). Additionally, the ARV values of 24-h systolic and diastolic 
BP showed similar patterns (Fig. 3); the highest values were in the 
WCH group, followed by the SHT, MHT, and NT groups. However, 
the SD lost significance after adjusting for covariates, with only 
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nighttime diastolic BPV between the WCH and SHT groups showing 
a statistically significant difference (7.9±0.4 vs. 8.7±0.3, p=0.002, 
Table 4). Daytime CoV was higher in the NT and WCH groups than 
the MHT and ST groups (Tables 3 and 4).
Discussion
We evaluated the relationship between WCH and BPV by using 
data from the Kor-ABP Registry. There are several BPV indexes. 
In this study, the NT and MHT groups had similar BPV values, 
whether presented as SD or ARV. The NT and WCT groups had 
a lower mean 24-h BP and had a higher CoV than the SHT and 
MHT groups. However, both the SD and CoV have a limitation: they 
cannot evaluate time series variability. The ARV is more reliable 
than the SD due to the presence of time series variability.10)19) Our 
data show that the SHT and WCH groups had a higher ARV than SD. 
These results persisted after adjusting for confounding variables, 
including sex, age, medical history of diabetes mellitus, BMI, serum 
creatinine, and cholesterol level.
Age and sex are closely related to BPV, and antihypertensive 
drugs including calcium channel blockers are known to decrease 
BPV.9) We adjusted BPV by using confounding variables based 
on previous studies on BPV5)20) with the variables that showed 
statistical differences in the baseline characteristics. We did not 
consider antihypertensive medication as a confounding variable, 
since our study population did not include treated hypertensive 
patients.
WCH is the isolated office HT in untreated patients, and it is 
distinguished from the white coat effect based on the antihypertensive 
treatment.21) However, Fagard and Cornelissen.4) mentioned that 
most of the studies about WCH with CV outcomes include patients 
undergoing antihypertensive treatment, which is a study limitation. 
In the baseline characteristics of this study, the WCH group had a 
younger mean age than the NT and MHT groups, a smaller abdominal 
circumference and BMI, and lower cholesterol and glucose levels 
than the MHT group. Their office BP level was compatible with 
grade 1 HT, with an average BP of 148.7/91.3 mmHg. Similar to our 
data, previous studies also reported patients with WCH usually have 
an office systolic BP of 140-159 mmHg or an office diastolic BP of 
90-99 mmHg.22)23) Additionally, female sex, being a nonsmoker, lower 
BMI, favorable lipid profile, and a smaller value of left ventricular 
mass (LVM) were suggested as independent predictors of WCH. 
Echo data was available for 639 of the 1398 subjects (data was 
not shown); the adjusted LVM index in the WCH group was smaller 
(94.6±3.3 g/m2) than the SHT group (102.9±6.6 g/m2, p=0.013) and 
similar to the two other groups (NT, 95.7±2.8; MHT, 94.4±3.3).
Contrary to our study, a recent report showed that short-term 
BPV compared to home BP was higher in the MHT and ST groups 
than the WCH and NT groups.20) This study had several differences 
compared to our current study, including the study population, the 
device for measuring out-of-office BP, and the index of BPV. They 
investigated elderly people who were ≥73 years old, assessed BPV 
with SD from 18 measurements of home BP, and included about 
50% of patients taking antihypertensive medication. As mentioned in 
our results, the average age of our study was 52.4 years, participants 
were not taking antihypertensive medication, and we evaluated 
BPV with ARV from 24-h ABPM. Hence, the different age, study 
population, measuring patterns, and index for BPV may have resulted 
in the different results.
BPV includes both short-term and long-term changes in BP, 
which can be measured by ABPM and visit-to-visit variability, 
respectively. Our data measured short-term BPV with ABPM. BPV, 
which represents the fluctuations in BP, depends on sympathetic 
vascular modulation and changes in arterial distensibility.24)25) 
A cohort study suggested that high BPV is associated with impaired 
endothelial function.26) BPV has been reported as a strong predictor 
of stroke, independent of mean systolic BP.11-13) Specific organs, 
in particular the vessels of the brain, are susceptible to transient 
elevations in BP. Therefore, stroke risk may be increased with BP 
surges related to WCH, compared to a normotensive control.16)27) 
BPV is closely associated with primary and secondary outcomes 
of stroke.12)13)16)19)27)28) However, fluctuations of BP in WCH are 
usually transient rather than persistent. The influence on adverse 
cardiovascular outcomes could be minimal compared to the effect 
of sustained high BP.16) Cardiovascular risk is known to be the 
highest in subjects with SHT, followed in order by MH, WCH, and 
NT.4)5)8) Hence, the highest ARV in the WCH group suggests one 
reason for cardiovascular or cerebrovascular risk in WCH, and it 
does not mean that WCH has the highest risk compared to the 
other groups. Moreover, many factors influenced WCH with BPV 
including age, sex, partial or true WCH, and whether the WCH was 
treated or untreated. Another study about long-term CV outcomes 
showed only a partial WCH-related increase in CV events compared 
to NT.6) Hence, a long-term follow up study of WCH with high BPV 
is needed for confirmation of the current study results.
This study had several limitations. First, it was based on data 
from secondary and tertiary hospitals, and did not include primary 
clinics. Additionally, this is a cross-sectional observational study 
with no follow-up data. Thus, it was difficult to establish any causal 
or temporal relationships. Based on previous data and this study, 
we suggest using ARV as one of risk factors of WCH-related long-
term vascular accidents. However, long-term prospective studies 
are needed for confirmation. In addition, the incidence of stroke 
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displays differences between races.29)30) All participants in the 
current study were Korean, and the results therefore cannot be 
generalized to other ethnic groups.
In conclusion, our data showed that the WCH and MHT groups 
had the higher ARV values, as calculated from the average absolute 
difference between consecutive measurements, compared to NT. 
However, long-term follow-up data are needed for the determination 
of clinical influences of WCH in stroke.
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